1/448
Comprehensive vocabulary review flashcards covering Chapter 46: SIRS, Sepsis, Shock, MODS, and Death.

Shock
A clinical state characterized by the inability of the heart and lungs to satisfy cellular metabolic and oxygen demands, defined hemodynamically by sustained tissue hypoperfusion.
Systolic Blood Pressure Threshold in Shock
A systolic blood pressure (SBP) reading of <90mm Hg, which serves as a common hemodynamic presentation of systemic hypoperfusion.
Relative Blood Pressure Reduction in Shock
An acute drop in systolic blood pressure of 40mm Hg or more below an individual patient's established baseline.

Diagnostic Value of Blood Pressure in Shock
The clinical reality that blood pressure measurements alone do NOT define shock, as cellular hypoperfusion can precede overt arterial hypotension.
Sustained Hypoperfusion
Prolonged inadequate capillary blood flow to vital peripheral and visceral tissues, leading directly to cellular hypoxia and organ failure.
Severe Hypotension
Marked reduction in systemic arterial pressure that directly results in inadequate microvascular perfusion pressure across end organs.

Care Setting for Shock Management
Intensive care units and critical care settings equipped for continuous hemodynamic monitoring and aggressive multidisciplinary intervention.
Monitoring Frequency in Shock
Continuous, minute-to-minute assessment of patient vital signs and multisystem organ function.

Epidemiological Incidence of Shock
An incidence rate that remains difficult to accurately calculate due to diverse underlying etiologies and overlapping definitions.
Severe Sepsis Mortality Rate
A patient mortality rate documented between 20% and 52% in clinical populations.
Septic Shock Mortality Rate
A severe mortality rate documented at 82% among afflicted patients.
Types of Shock
The five principal clinical classifications of shock: cardiogenic, hypovolemic, anaphylactic, neurogenic, and septic.
Cardiogenic Shock (Etiological Definition)
A primary circulatory failure state resulting directly from catastrophic pump dysfunction or failure of the heart.
Hypovolemic Shock (Etiological Definition)
Circulatory collapse caused by the critical loss of large quantities of circulating whole blood or extracellular body fluids.
Anaphylactic Shock (Etiological Definition)
Distributive circulatory collapse caused by a severe, systemic acute allergic reaction triggering massive vasodilation.
Neurogenic Shock (Etiological Definition)
Distributive shock caused by acute disruption of descending autonomic pathways following injury to the spinal cord or brain.
Septic Shock (Etiological Definition)
Distributive circulatory failure driven by severe systemic dysregulation in response to overwhelming infection.
Physiological Convergence of Shock
The universal pathophysiological trajectory shared by all forms of shock, terminating in inadequate blood flow, cellular hypoxia, and systemic compensatory cascades.

Foundational Principle of Shock Management
The clinical truth that prevention is clearly superior to the delivery of even perfect reactive medical treatment.
Timing of Shock Therapy Initiation
The mandatory clinical directive to initiate appropriate, targeted therapeutic intervention without any delay.

Cardiogenic Shock Prevention Strategy
The rapid, prompt medical and reperfusion treatment of acute myocardial infarction (MI) to protect functioning myocardium.
Sepsis Prevention Protocol
Meticulous and strict clinical adherence to handwashing hygiene and sterile medical instrumentation protocols.

Complexity of Shock Therapeutics
Medical management that is highly complicated, dictated entirely by underlying etiology, and dependent on multiple specialists.
Initial Stage of Shock
The early phase of shock initiated by a sudden drop in tissue perfusion, characterized by compensatory activation of the SNS and RAAS.
Goal of the Initial Stage of Shock
Autonomic and neurohormonal compensation aimed at maintaining systemic tissue perfusion pressures.
Sympathetic Nervous System (SNS) Activation in Shock
Rapid compensatory neuroendocrine activation in the initial stage of shock triggering tachycardia, peripheral vasoconstriction, and pallor.
Renin-Angiotensin-Aldosterone System (RAAS) Activation in Shock
A renal hormonal response triggered by reduced renal artery perfusion to conserve intravascular sodium, water, and systemic pressure.
Heart Rate in the Initial Stage of Shock
Compensatory tachycardia (increased heart rate) mediated by sympathetic catecholamine release on cardiac adrenergic receptors.
Mental Status in the Initial Stage of Shock
Mild cerebral hypoperfusion and adrenergic stimulation presenting clinically as patient anxiety and restlessness.
Respiratory Rate in the Initial Stage of Shock
Tachypnea (increased respiratory rate) initiated to enhance alveolar gas exchange and compensate for early metabolic shifts.
Skin Appearance in the Initial Stage of Shock
Cutaneous pallor (pale skin) caused by alpha-1 adrenergic vasoconstriction shunting capillary blood away from the skin to vital organs.
Progressive Stage of Shock
The second phase of shock where compensatory mechanisms falter, resulting in hypoperfusion of the lungs, kidneys, gut, pancreas, and liver.
Goal of the Progressive Stage of Shock
Intense selective vasoconstriction aimed at conserving circulating blood flow exclusively for the heart and the brain.
Pulmonary Perfusion in Progressive Shock
A critical decline in capillary blood flow through the lungs, impairing gas exchange and oxygen delivery.
Renal Perfusion in Progressive Shock
Severe hypoperfusion of renal parenchyma resulting in reduced glomerular filtration rate (GFR) and oliguria.
Glomerular Filtration Rate (GFR) in Shock
The filtration rate of the kidneys, which markedly decreases during the progressive stage, precipitating toxic metabolic waste buildup.
Metabolic Toxin Accumulation in Shock
The rapid systemic retention of nitrogenous wastes and metabolic byproducts caused by renal dysfunction and poor visceral perfusion.
Gastrointestinal Peristalsis in Shock
Decreased bowel motility and peristalsis resulting from intense splanchnic vasoconstriction during progressive shock.
Pancreatic Dysfunction in Progressive Shock
Hypoperfusion of the pancreas resulting in impaired endocrine and exocrine functional capacity.
Hepatic Dysfunction in Progressive Shock
Compromised liver microcirculation leading to decreased clearance of metabolic toxins, lactic acid, and activated clotting factors.
Irreversible Stage of Shock
The terminal phase of shock characterized by myocardial and cerebral ischemia, widespread cellular hypoxia, organelle breakdown, and cell death.
Myocardial Ischemia in Irreversible Shock
Profound hypoperfusion of the coronary arteries depriving cardiomyocytes of oxygen and severely depressing myocardial contractility.
Cerebral Ischemia in Irreversible Shock
Critical loss of cerebral perfusion pressure and blood flow, resulting in ischemic brain injury, coma, and brain death.
Widespread Cellular Hypoxia
Pervasive deprivation of cellular oxygen across all body tissues due to uncorrected microvascular hypoperfusion.
Anaerobic Metabolism in Shock
An emergency intracellular metabolic pathway activated when lack of oxygen halts oxidative phosphorylation in mitochondria.
Loss of Cellular Function in Shock
The cessation of membrane transport, ion pump activity, and protein synthesis as cellular energy supplies collapse.
Organelle Failure in Shock
The breakdown of mitochondrial structure, endoplasmic reticulum integrity, and nuclear homeostasis preceding cell death.
Lysosomal Enzyme Release
The rupture of fragile lysosomal membranes within dying cells, releasing hydrolytic and digestive enzymes that autodigest surrounding tissue.
Inflammatory Response to Shock
A massive systemic inflammatory state stimulated directly by widespread cellular necrosis and damage-associated molecular patterns.
Massive Cytokine Release
The profound systemic unloading of pro-inflammatory cytokines into circulation following cell lysis, worsening endothelial injury.
Lactic Acidosis in Shock
Metabolic acidemia caused by the systemic buildup of lactic acid resulting from persistent cellular hypoxia and anaerobic glycolysis.
Adverse Effects of Lactic Acidosis
Impaired myocardial contractility, reduced vascular responsiveness to catecholamines, enzyme dysfunction, and peripheral cellular injury.

Anaerobic ATP Yield
The production of only 2ATP molecules along with lactic acid per glucose molecule metabolized under anaerobic conditions.
Bodywide Lactic Acidosis
The systemic accumulation of lactic acid across all organ beds as anaerobic metabolism dominates whole-body physiology.
Gastrointestinal Mucosal Barrier Integrity
The structural cellular seal of the intestinal mucosa, which rapidly degrades under sustained splanchnic ischemia in shock.
Intestinal Bacterial Translocation
The entry of luminal gut contents, bacteria, and endotoxins directly into the bloodstream through a degraded mucosal lining to ignite systemic inflammation.
Endothelial Capillary Integrity
The semipermeable barrier of microvascular endothelial cells, which fails in shock, causing fluid, albumin, and solute leakage.
Intestinal Edema
Pathological extravasation of fluid into the wall and submucosa of the intestines secondary to loss of capillary membrane integrity.
Intestinal Third Space Fluid Loss
The sequestration of intravascular fluids into the intestinal interstitial space, causing severe functional hypovolemia.
Stress Hormone Surges in Shock
Marked elevations of circulating epinephrine and cortisol produced by the adrenal glands to mobilize resources during acute hypoperfusion.
Insulin Resistance of Shock
The physiological inhibition of insulin action driven by elevated levels of epinephrine and cortisol, precipitating stress hyperglycemia.
Microvascular Clot Formation in Shock
Pathological platelet aggregation and widespread fibrin deposition within capillary networks triggered by endothelial damage.
Fibrinolytic Pathway Inhibition in Shock
The impairment of endogenous clot-dissolving mechanisms, promoting microthrombi persistence and downstream ischemic necrosis.
Tissue Ischemia from Coagulopathy
Microvascular occlusion by persistent fibrin thrombi that blocks nutritional blood flow to organ beds.
Diagnostic Blood Pressure Criterion in Cardiogenic Shock
A persistent systolic blood pressure <90mm Hg sustained continuously for at least 30minutes.
Fluid Status Requirement in Cardiogenic Shock
The persistence of severe hypotension and tissue hypoperfusion despite the confirmed administration of adequate intravascular fluid volume.
Primary Hemodynamic Defect in Cardiogenic Shock
Inability of the left and/or right ventricles to generate sufficient forward pressure to perfuse vital systemic tissues.
Arrhythmias (Cardiogenic Shock Etiology)
Severe cardiac rhythm disturbances (such as ventricular tachycardia, severe bradycardia, or atrial fibrillation) compromising stroke volume.
Cardiac Tamponade (Definition)
The pathological accumulation of fluid or blood within the pericardial sac surrounding the heart, compressing cardiac chambers.
Urine Output in Cardiogenic Shock
Oliguria or low urine output resulting from diminished renal perfusion pressure and reduced glomerular capillary filtration.
Cyanosis in Cardiogenic Shock
Bluish discoloration of the skin and mucous membranes indicating high levels of deoxygenated hemoglobin due to stagnant microcirculation.
Mental Status in Cardiogenic Shock
Altered mental status presenting as confusion, stupor, or lethargy secondary to inadequate cerebral arterial perfusion.
Heart Rate in Cardiogenic Shock
Elevated heart rate (sinus tachycardia or tachyarrhythmias) acting as a compensatory response to low stroke volume.
Pulsus Paradoxus
A clinical finding wherein jugular vein pressure increases during inspiration due to fluid backup caused by external pressure on the heart.
Jugular Vein Pressure Dynamics in Inspiration
The paradoxical rise in jugular venous distension during inspiration when pericardial constraint prevents right ventricular expansion.
Fluid Backup in Jugular Veins
Retrograde venous congestion into the neck veins secondary to elevated right ventricular filling pressures in cardiac tamponade.
Beck's Triad
A classic diagnostic triad of cardiac tamponade consisting of distant heart sounds, low blood pressure, and high jugular vein pressure.
Distant Heart Sounds (Beck's Triad)
Muffled or softened heart sounds upon auscultation, caused by acoustic dampening by pericardial effusion.
Low Blood Pressure (Beck's Triad)
Arterial hypotension resulting from mechanical restriction of ventricular diastolic filling and depressed stroke volume.
High Jugular Vein Pressure (Beck's Triad)
Marked jugular venous distension reflecting elevated central venous pressure from impaired right atrial inflow.
Postural Orthostatic Tachycardia Syndrome (POTS)
A form of dysautonomia characterized by abnormal orthostatic heart rate acceleration and impaired blood volume distribution.

Hypovolemic POTS
A POTS subtype marked by reduced circulating absolute blood volume, excessive lower body blood pooling, and poor cardiac filling upon standing.
Normal Blood Distribution
Equilibrated central and peripheral blood volume that maintains adequate cardiac preload and cerebral perfusion across postural changes.
Lower Body Venous Pooling
Pathological gravitational settling of circulating blood volume into the splanchnic and lower limb venous capacitance vessels.

Left Ventricular Assist Device (LVAD)
A surgically implanted mechanical circulatory support device designed to offload a failing left ventricle by pumping blood directly into the aorta.
LVAD Inflow Tube
The specialized conduit through which blood from the left ventricle enters the LVAD pump mechanism.
LVAD Pump
The electromechanical pumping unit that continuously pulls blood from the left ventricular apex and pressurizes it into systemic circulation.
LVAD Outflow Conduit
The graft tube through which blood from the LVAD is propelled upward into the ascending aorta.
Aorta (in LVAD Configuration)
The main systemic artery that receives pumped blood from the LVAD outflow tube to perfuse vital organs.
LVAD Driveline Cable
The percutaneous electrical cable extending from the internal LVAD pump to the external power and control systems.
LVAD Computerized Controller
The external computerized device that regulates LVAD pump speed, monitors flows, and displays diagnostic alerts and alarms.
LVAD External Battery Pack
Wearable external power batteries connected via harness to power the continuous operation of the LVAD pump.
Left Ventricle (in LVAD Physiology)
The primary pumping chamber of the heart whose compromised output is supplemented or replaced by the LVAD.
Stop Fluid Loss
The immediate primary clinical objective in hypovolemic shock to arrest hemorrhage or external volume wasting.
Rapid Fluid Replacement
The prompt intravenous administration of fluids to restore depleted intravascular circulating volume and stabilize preload.
Volume Expanders
Intravenous crystalloid or colloid solutions administered as the first-line intervention to expand circulating blood volume in hypovolemia.

Blood Transfusion in Hypovolemic Shock
The administration of packed red blood cells and blood products required when fluid loss involves severe hemorrhage or profound anemia.
Urine Output as a Fluid Resuscitation Guide
The quantitative clinical monitoring of urine volume to assess the adequacy of renal perfusion and guide replacement fluid volume.

Lactated Ringer's Injection USP
A sterile, nonpyrogenic balanced crystalloid fluid designed for intravenous administration in fluid replenishment and acute resuscitation.
Lactated Ringer's Sodium Chloride Content
The specific chemical component present at 600mg per 100mL of Lactated Ringer's solution.